Latest operating income for CLNNW: $-21M.
Get informed when a big investor buys or sells
+ FollowAs of Jun 30, 2026
Trailing 12 months ending Jun 30, 2026
As of the most recent data (June 2026), CLNNW shows a operating income of $-21M. That compares with $-26M in the prior-year period — up 22.2% year over year. Scroll down for historical charts and peer comparison views.
Compared with the year-ago period, CLNNW's operating income is now $-21M (was $-26M) — a 22.2% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Clene- Warrants (30/12/2025) is outperforming or lagging.
Tracking CLNNW's operating income over time shows whether Clene- Warrants (30/12/2025) is scaling, shrinking, or reshaping that part of the business. The current reading is $-21M That compares with $-26M in the prior-year period — up 22.2% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.
Besides this operating income page, Stockcircle has Clene- Warrants (30/12/2025)'s full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect operating income (currently $-21M) with ownership activity and broader fundamentals.
Clene- Warrants (30/12/2025)'s operating income is $-21M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.